Global and China Cancer Anorexia-Cachexia Syndrome Drug Market Insights, Forecast to 2026

Global and China Cancer Anorexia-Cachexia Syndrome Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Cancer Anorexia-Cachexia Syndrome Drug Product Introduction
1.2 Market Segments
1.3 Key Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Type
1.4.2 NEO-1940
1.4.3 C-1889
1.4.4 DLN-101
1.4.5 Foxo1-nRNA
1.4.6 AVGN-7
1.4.7 Others
1.5 Market by Application
1.5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size, Estimates and Forecasts
2.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue 2015-2026
2.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales 2015-2026
2.2 Global Cancer Anorexia-Cachexia Syndrome Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Cancer Anorexia-Cachexia Syndrome Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Cancer Anorexia-Cachexia Syndrome Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Region (2021-2026)
3 Global Cancer Anorexia-Cachexia Syndrome Drug Competitor Landscape by Players
3.1 Global Top Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers
3.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers by Revenue
3.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Anorexia-Cachexia Syndrome Drug Revenue in 2019
3.2.5 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Manufacturers
3.4 Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base Distribution, Product Types
3.4.1 Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Anorexia-Cachexia Syndrome Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type (2015-2020)
4.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020)
4.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2015-2020)
4.1.3 Cancer Anorexia-Cachexia Syndrome Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Anorexia-Cachexia Syndrome Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application (2015-2020)
5.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020)
5.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2015-2020)
5.1.3 Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2015-2020)
5.2 Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Cancer Anorexia-Cachexia Syndrome Drug Market Size YoY Growth 2015-2026
6.1.1 China Cancer Anorexia-Cachexia Syndrome Drug Sales YoY Growth 2015-2026
6.1.2 China Cancer Anorexia-Cachexia Syndrome Drug Revenue YoY Growth 2015-2026
6.1.3 China Cancer Anorexia-Cachexia Syndrome Drug Market Share in Global Market 2015-2026
6.2 China Cancer Anorexia-Cachexia Syndrome Drug Market Size by Players (International and Local Players)
6.2.1 China Top Cancer Anorexia-Cachexia Syndrome Drug Players by Sales (2015-2020)
6.2.2 China Top Cancer Anorexia-Cachexia Syndrome Drug Players by Revenue (2015-2020)
6.3 China Cancer Anorexia-Cachexia Syndrome Drug Historic Market Review by Type (2015-2020)
6.3.1 China Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
6.3.2 China Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2015-2020)
6.4 China Cancer Anorexia-Cachexia Syndrome Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2021-2026)
6.4.2 China Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Cancer Anorexia-Cachexia Syndrome Drug Price Forecast by Type (2021-2026)
6.5 China Cancer Anorexia-Cachexia Syndrome Drug Historic Market Review by Application (2015-2020)
6.5.1 China Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
6.5.2 China Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2015-2020)
6.6 China Cancer Anorexia-Cachexia Syndrome Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2021-2026)
6.6.2 China Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Cancer Anorexia-Cachexia Syndrome Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size YoY Growth 2015-2026
7.2 North America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
7.2.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020)
7.2.2 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size YoY Growth 2015-2026
8.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
8.2.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
8.2.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size YoY Growth 2015-2026
10.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
10.2.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
10.2.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
11.2.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Acacia Pharma Ltd
12.1.1 Acacia Pharma Ltd Corporation Information
12.1.2 Acacia Pharma Ltd Description and Business Overview
12.1.3 Acacia Pharma Ltd Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.1.5 Acacia Pharma Ltd Recent Development
12.2 Aeterna Zentaris Inc
12.2.1 Aeterna Zentaris Inc Corporation Information
12.2.2 Aeterna Zentaris Inc Description and Business Overview
12.2.3 Aeterna Zentaris Inc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.2.5 Aeterna Zentaris Inc Recent Development
12.3 Aphios Corp
12.3.1 Aphios Corp Corporation Information
12.3.2 Aphios Corp Description and Business Overview
12.3.3 Aphios Corp Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.3.5 Aphios Corp Recent Development
12.4 Incyte Corp
12.4.1 Incyte Corp Corporation Information
12.4.2 Incyte Corp Description and Business Overview
12.4.3 Incyte Corp Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.4.5 Incyte Corp Recent Development
12.5 Lakewood-Amedex Inc
12.5.1 Lakewood-Amedex Inc Corporation Information
12.5.2 Lakewood-Amedex Inc Description and Business Overview
12.5.3 Lakewood-Amedex Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.5.5 Lakewood-Amedex Inc Recent Development
12.6 Novartis AG
12.6.1 Novartis AG Corporation Information
12.6.2 Novartis AG Description and Business Overview
12.6.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.6.5 Novartis AG Recent Development
12.7 Obexia AG
12.7.1 Obexia AG Corporation Information
12.7.2 Obexia AG Description and Business Overview
12.7.3 Obexia AG Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.7.5 Obexia AG Recent Development
12.8 PsiOxus Therapeutics Ltd
12.8.1 PsiOxus Therapeutics Ltd Corporation Information
12.8.2 PsiOxus Therapeutics Ltd Description and Business Overview
12.8.3 PsiOxus Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
12.8.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.8.5 PsiOxus Therapeutics Ltd Recent Development
12.9 RaQualia Pharma Inc
12.9.1 RaQualia Pharma Inc Corporation Information
12.9.2 RaQualia Pharma Inc Description and Business Overview
12.9.3 RaQualia Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.9.5 RaQualia Pharma Inc Recent Development
12.10 Viking Therapeutics Inc
12.10.1 Viking Therapeutics Inc Corporation Information
12.10.2 Viking Therapeutics Inc Description and Business Overview
12.10.3 Viking Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.10.5 Viking Therapeutics Inc Recent Development
12.11 Acacia Pharma Ltd
12.11.1 Acacia Pharma Ltd Corporation Information
12.11.2 Acacia Pharma Ltd Description and Business Overview
12.11.3 Acacia Pharma Ltd Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Products Offered
12.11.5 Acacia Pharma Ltd Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Cancer Anorexia-Cachexia Syndrome Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Anorexia-Cachexia Syndrome Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Cancer Anorexia-Cachexia Syndrome Drug Market Segments
Table 2. Ranking of Global Top Cancer Anorexia-Cachexia Syndrome Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of NEO-1940
Table 5. Major Manufacturers of C-1889
Table 6. Major Manufacturers of DLN-101
Table 7. Major Manufacturers of Foxo1-nRNA
Table 8. Major Manufacturers of AVGN-7
Table 9. Major Manufacturers of Others
Table 10. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Cancer Anorexia-Cachexia Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Anorexia-Cachexia Syndrome Drug as of 2019)
Table 20. Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Price (2015-2020) (USD/Pcs)
Table 23. Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
Table 25. Date of International Manufacturers Enter into Cancer Anorexia-Cachexia Syndrome Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 28. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2015-2020)
Table 29. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2015-2020)
Table 31. Cancer Anorexia-Cachexia Syndrome Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2021-2026)
Table 33. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 34. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2015-2020)
Table 35. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2021-2026)
Table 36. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Application (2021-2026)
Table 39. China Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 40. China Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Company (2015-2020)
Table 41. China Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) by Company (2015-2020)
Table 42. China Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 43. China Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2015-2020)
Table 44. China Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. China Cancer Anorexia-Cachexia Syndrome Drug Price (K Pcs) by Type (2015-2020)
Table 46. China Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2021-2026)
Table 47. China Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2021-2026)
Table 48. China Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2021-2026)
Table 50. China Cancer Anorexia-Cachexia Syndrome Drug Price (K Pcs) by Type (2021-2026)
Table 51. China Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 52. China Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2015-2020)
Table 53. China Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. China Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Application (2021-2026)
Table 55. China Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2021-2026)
Table 56. China Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2021-2026)
Table 58. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 59. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 60. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 62. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 63. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 64. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2015-2020)
Table 70. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 78. Acacia Pharma Ltd Corporation Information
Table 79. Acacia Pharma Ltd Description and Business Overview
Table 80. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product
Table 82. Acacia Pharma Ltd Recent Development
Table 83. Aeterna Zentaris Inc Corporation Information
Table 84. Aeterna Zentaris Inc Description and Business Overview
Table 85. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Aeterna Zentaris Inc Product
Table 87. Aeterna Zentaris Inc Recent Development
Table 88. Aphios Corp Corporation Information
Table 89. Aphios Corp Description and Business Overview
Table 90. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Aphios Corp Product
Table 92. Aphios Corp Recent Development
Table 93. Incyte Corp Corporation Information
Table 94. Incyte Corp Description and Business Overview
Table 95. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Incyte Corp Product
Table 97. Incyte Corp Recent Development
Table 98. Lakewood-Amedex Inc Corporation Information
Table 99. Lakewood-Amedex Inc Description and Business Overview
Table 100. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Lakewood-Amedex Inc Product
Table 102. Lakewood-Amedex Inc Recent Development
Table 103. Novartis AG Corporation Information
Table 104. Novartis AG Description and Business Overview
Table 105. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Novartis AG Product
Table 107. Novartis AG Recent Development
Table 108. Obexia AG Corporation Information
Table 109. Obexia AG Description and Business Overview
Table 110. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Obexia AG Product
Table 112. Obexia AG Recent Development
Table 113. PsiOxus Therapeutics Ltd Corporation Information
Table 114. PsiOxus Therapeutics Ltd Description and Business Overview
Table 115. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. PsiOxus Therapeutics Ltd Product
Table 117. PsiOxus Therapeutics Ltd Recent Development
Table 118. RaQualia Pharma Inc Corporation Information
Table 119. RaQualia Pharma Inc Description and Business Overview
Table 120. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. RaQualia Pharma Inc Product
Table 122. RaQualia Pharma Inc Recent Development
Table 123. Viking Therapeutics Inc Corporation Information
Table 124. Viking Therapeutics Inc Description and Business Overview
Table 125. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Viking Therapeutics Inc Product
Table 127. Viking Therapeutics Inc Recent Development
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Cancer Anorexia-Cachexia Syndrome Drug Players
Table 132. Cancer Anorexia-Cachexia Syndrome Drug Customers List
Table 133. Cancer Anorexia-Cachexia Syndrome Drug Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Anorexia-Cachexia Syndrome Drug Product Picture
Figure 2. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2020 & 2026
Figure 3. NEO-1940 Product Picture
Figure 4. C-1889 Product Picture
Figure 5. DLN-101 Product Picture
Figure 6. Foxo1-nRNA Product Picture
Figure 7. AVGN-7 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Cancer Anorexia-Cachexia Syndrome Drug Report Years Considered
Figure 14. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2019
Figure 19. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region in 2019
Figure 21. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Cancer Anorexia-Cachexia Syndrome Drug Revenue in 2019
Figure 23. Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2019
Figure 26. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type in 2019
Figure 28. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Price Range (2015-2020)
Figure 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2019
Figure 31. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application in 2019
Figure 33. China Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. China Cancer Anorexia-Cachexia Syndrome Drug Market Share in Global Market 2015-2026
Figure 36. China 5 and 10 Largest Cancer Anorexia-Cachexia Syndrome Drug Players Market Share by Revenue in Cancer Anorexia-Cachexia Syndrome Drug in 2019
Figure 37. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2015-2020)
Figure 38. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 39. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2015-2020)
Figure 40. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2019
Figure 44. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2019
Figure 45. U.S. Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2019
Figure 52. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2019
Figure 53. Germany Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2019
Figure 66. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region in 2019
Figure 67. China Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwa

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs